[1]张文波,杨玉雯.希氏束起搏在慢性心力衰竭患者中的应用[J].医学信息,2019,32(10):41-43.[doi:10.3969/j.issn.1006-1959.2019.10.015]
　ZHANG Wen-bo,YANG Yu-wen.Application of His Bundle Pacing in Patients with Chronic Heart Failure[J].Journal of Medical Information,2019,32(10):41-43.[doi:10.3969/j.issn.1006-1959.2019.10.015]
点击复制

希氏束起搏在慢性心力衰竭患者中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年10期
页码:
41-43
栏目:
综述
出版日期:
2019-05-15

文章信息/Info

Title:
Application of His Bundle Pacing in Patients with Chronic Heart Failure
文章编号:
1006-1959（2019）10-0041-03
作者:
张文波; 杨玉雯
（皖南医学院第一附属医院心血管内科，安徽 芜湖 241001）
Author(s):
ZHANG Wen-bo; YANG Yu-wen
(Department of Cardiology,the First Affiliated Hospital of Wannan Medical College,Wuhu 241001,Anhui,China)
关键词:
希氏束起搏; 慢性心力衰竭; 心脏再同步化治疗; 房颤; 房室结消融
Keywords:
His bundle pacing; Chronic heart failure; Cardiac resynchronization therapy; Atrial fibrillation; Atrioventricular node ablation
分类号:
R541.6
DOI:
10.3969/j.issn.1006-1959.2019.10.015
文献标志码:
A
摘要:
希氏束-浦肯野纤维是心脏传导系统的重要组成部分，希氏束起搏（HBP）是通过自身希氏束-浦肯野纤维系统传导，具有保留心脏机械同步性的优势，是目前最生理性的心脏起搏方式，可避免心室收缩的不同步，减少心力衰竭的发生。HBP分为选择性希氏束起搏和非选择性希氏束起搏。对于需要高比例心室起搏、右室起搏导致心功能恶化、因房颤合并心衰行房室结消融控制心室率以及部分符合CRT适应证的患者，希氏束起搏可显著改善心功能，本文就此进行阐述。
Abstract:
His bundle-Purkinje fiber is an important part of the heart conduction system. His bundle pacing (HBP) is transmitted through its own His bundle-Purkinje fiber system, which has the advantage of retaining the mechanical synchronism of the heart. The most physiological cardiac pacing method can avoid the ventricular contraction and reduce the occurrence of heart failure. HBP is divided into selective His bundle pacing and non-selective His bundle pacing. Histilb pacing can significantly improve cardiac function in patients requiring high-grade ventricular pacing, right ventricular pacing leading to deterioration of cardiac function, and atrioventricular node ablation to control ventricular rate due to atrial fibrillation and heart failure, and partial compliance with CRT indications. This article explains this.

参考文献/References:

[1]Deshmukh P,Casavant DA,Romanyshyn M,et al.Permanent direct His-bundle pacing：a novel approach to cardiac pacing in patients with normal His-Purkinje activation[J].Circulation,2000,101(8):869-877.
[2]Huang W,Su L,Wu S,et al.A novel pacing strategy with low and stable output：pacing the left bundle branch immediately beyond the conduction block[J]. Can J Cardiol,2017,33(12):1736.e1-1376.e3.
[3]Vijayaraman P,Dandamudi G,Zanon F,et al.Permanent His bundle pacing:recommendations from a multicenter His Bundle Pacing Collaborative Working Group for standardization of definitions, implant measurements,and follow-up[J].Heart Rhythm,2018,15(3):460-468.
[4]苏蓝,吴高俊,李海鹰,等．3830导线在选择性心室起搏的应用及近期安全性观察[J].中国心脏起搏与心电生理杂志,2014,8(3):236-239.
[5]盛夏,潘轶文,张杰芳,等.永久希氏束起搏的长期安全性和可行性分析[J].中华心律失常学杂志,2018,22(2):100-104.
[6]Zanon F,Ellenbogen KA,Dandamudi G,et al.Permanent his-Bundle pacing:a systematic literature review and meta-analysis[J].Europace,2018,20(11):1819-1826.
[7]Sharma PS,Dandamudi G,Naperkowski A,et al.Permanent Hisbundle pacing is feasible,safe,and superior to right ventricular pacing in routine clinical practice[J].Heart Rhythm,2015,12(2): 305-312.
[8]Zanon F,Svetlich C,Occhetta E,etal.Safety and performance of a system specifically designed for selective site pacing[J].Pacing Clin Electrophysiol,2011,34(3):339-347.
[9]钱智勇,王矗,邱垣皓,等.希氏束起搏患者导线长期稳定性的观察[J].中华心律失常学杂志,2018,22(2):95-99.
[10]Sweeney MO,Hellkamp AS,Ellenbogen KA,et al.Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction[J].Circulation,2003,107(23):2932-2937.
[11]Wilkof BL,Cook JR,Epstein AE,et al.Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator:the Dual Chamber and VVI Implantable Defibrillator(DAVID) Trial[J].JAMA,2002,288(24):3115-3123.
[12]Zanon F,Baracca E,Ramin L,et al.Direct his bundle pacing preserves coronary perfusion compared with right ventricular apical pacing:a prospective,cross-over midterm study[J].Europace,2008,10(5):580-587.
[13]王垚,钱智勇,张金龙,等.希氏束起搏对心脏机械同步性的影响[J].中华心律失常学杂志,2018,22(2):117-122.
[14]Kronborg MB,Mortensen PT,Gerdes JC,et al.His and para-His pacing in AV block:Feasibility and electrocardiographic findings[J].J Interv Card Electrophysiol,2011,31(3):255-262.
[15]Abdelrahman M,Suhzposh FA,Beer D,et al.Clinical outcomes of His bundle pacing compared to right ventricular pacing[J].J Am Coll Cardiol,2018,71(20):2319-2330.
[16]Vijayaraman P,Subzposh FA,Naperkowski A.Atrioventricular node ablation and His bundle pacing[J].Europace,2017,19(Suppl 4):iv10-iv16.
[17]Huang W,Su L,Wu S,et al.Benefits of permanent His bundle pacing combined with atrioventricular node ablation in atrial fibrillation patients with heart failure with both preserved and reduced left ventricular ejection fraction[J].J Am Heart Assoc,2017,6(4):e005309.
[18]Barba-Pichardo R,Manovel Sánchez A,Fernández-Gómez JM,et al.Ventricular resynchronization therapy by direct His-bundle pacing using an internal cardioverter defibrillator[J].Europace,2013,15(1):83-88.
[19]Sharma PS,Dandamudi G,Herweg B,et al.Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy:A multi center experience[J].Heart Rhythm,2018,15(3):4l3-420.
[20]Sharma PS,Huizar J,Eilenbogen KA,et al.Recruitment of bundle branches with permanent His-bundle pacing in a patient with advanced conduction system disease: What is the mechanism? [J].Heart Rhythm,2016,13(2):623-625.
[21]Abdelrahman M,Subzposh FA,Beer D,et al.Clinical outcomes of His bundle pacing compared to right ventricular pacing[J].J Am Coll Cardiol,2018,71(20):2319-2330.
[22]于海波,梁延春,王娜,等.希氏束起搏在希氏-浦肯野系统传导病变心力衰竭患者中的应用[J].中华心律失常学杂志,2018,22(2):105-110.

相似文献/References:

[1]贺明清,刘孝娅.环磷腺苷葡胺治疗慢性心力衰竭临床疗效观察[J].医学信息,2018,31(10):135.[doi:10.3969/j.issn.1006-1959.2018.10.045]
　HE Ming-qing,LIU Xiao-ya.Clinical Efficacy of Cyclic Adenosine Glucosamine in the Treatment of Chronic Heart Failure[J].Journal of Medical Information,2018,31(10):135.[doi:10.3969/j.issn.1006-1959.2018.10.045]
[2]李鹏飞,何荣华,王琼涛,等.单胺氧化酶对老年心力衰竭患者临床应用价值[J].医学信息,2018,31(17):78.[doi:10.3969/j.issn.1006-1959.2018.17.023]
　LI Peng-fei,HE Rong-hua,WANG Qiong-tao,et al.Clinical Value of Monoamine Oxidase in Elderly Patients with Heart Failure[J].Journal of Medical Information,2018,31(10):78.[doi:10.3969/j.issn.1006-1959.2018.17.023]
[3]曹 云,李树茂,裘 冬,等.益气温阳中药治疗慢性舒张性心力衰竭的疗效观察[J].医学信息,2019,32(01):162.[doi:10.3969/j.issn.1006-1959.2019.01.051]
　CAO Yun,LI Shu-mao,QIU Dong,et al.Therapeutic Effect of Yiqiwenyang Chinese Medicine on Chronic Diastolic Heart Failure[J].Journal of Medical Information,2019,32(10):162.[doi:10.3969/j.issn.1006-1959.2019.01.051]
[4]韩婷婷,王 虹,吴美美,等.N-proBNP对慢性心衰患者发生肺动脉高压的预测价值[J].医学信息,2019,32(05):114.[doi:10.3969/j.issn.1006-1959.2019.05.035]
　HAN Ting-ting,WANG Hong,WU Mei-mei,et al.Predictive Value of N-proBNP for Pulmonary Hypertension in Patients with Chronic Heart Failure[J].Journal of Medical Information,2019,32(10):114.[doi:10.3969/j.issn.1006-1959.2019.05.035]
[5]李 月,胡 雅,曹春乐,等.慢性心力衰竭患者健康心理控制源与自我管理的相关性研究[J].医学信息,2019,32(05):133.[doi:10.3969/j.issn.1006-1959.2019.05.042]
　LI Yue,HU Ya,CAO Chun-le,et al.Correlation between Health Psychological Control Sources and Self-management in Patients with Chronic Heart Failure[J].Journal of Medical Information,2019,32(10):133.[doi:10.3969/j.issn.1006-1959.2019.05.042]
[6]张凤娜,高伟勤.6min步行试验训练对慢性心力衰竭患者心功能的影响[J].医学信息,2019,32(16):97.[doi:10.3969/j.issn.1006-1959.2019.16.030]
　ZHANG Feng-na,GAO Wei-qin.The Effect of 6min Walking Test Training on Cardiac Function in Patients with Chronic Heart Failure[J].Journal of Medical Information,2019,32(10):97.[doi:10.3969/j.issn.1006-1959.2019.16.030]
[7]蒲军亮,张 婷.沙库巴曲缬沙坦钠片联合琥珀酸美托洛尔缓释片治疗慢性心力衰竭的疗效观察[J].医学信息,2020,33(14):159.[doi:10.3969/j.issn.1006-1959.2020.14.051]
　PU Jun-liang,ZHANG Ting.Observation of Sacubitril Valsartan Sodium Tablets Combined with Metoprolol Succinate Sustained-release Tablets in the Treatment of Chronic Heart Failure[J].Journal of Medical Information,2020,33(10):159.[doi:10.3969/j.issn.1006-1959.2020.14.051]
[8]杜蔚蓓,张建伟.CHF患者血清甲状腺激素异常及小剂量左甲状腺素钠治疗的效果[J].医学信息,2020,33(15):73.[doi:10.3969/j.issn.1006-1959.2020.15.023]
　DU Wei-bei,ZHANG Jian-wei.Serum Thyroid Hormone Abnormalities in CHF Patients and the Effect of Low-dose Levothyroxine Sodium Therapy[J].Journal of Medical Information,2020,33(10):73.[doi:10.3969/j.issn.1006-1959.2020.15.023]
[9]袁 超.沙库巴曲缬沙坦联合比索洛尔治疗慢性心力衰竭的效果[J].医学信息,2020,33(19):135.[doi:10.3969/j.issn.1006-1959.2020.19.041]
　YUAN Chao.Effect of Sacubitril Valsartan Combined with Bisoprolol in the Treatment of Chronic Heart Failure[J].Journal of Medical Information,2020,33(10):135.[doi:10.3969/j.issn.1006-1959.2020.19.041]
[10]桑明敏,朱芳一,祝存奎,等.芪参益气滴丸联合美托洛尔治疗原发性高血压病合并慢性心衰的疗效[J].医学信息,2020,33(21):157.[doi:10.3969/j.issn.1006-1959.2020.21.049]
　SANG Ming-min,ZHU Fang-yi,ZHU Cun-kui,et al.Effect of Qishen Yiqi Dropping Pills and Metoprolol in the Treatment of Essential Hypertension with Chronic Heart Failure[J].Journal of Medical Information,2020,33(10):157.[doi:10.3969/j.issn.1006-1959.2020.21.049]

更新日期/Last Update: 2019-05-15